Vext Science, Inc.
Other OTCRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Vext Science, Inc. operates as an integrated agricultural technology, services, and property management company within the cannabis industry in the United States. The company manufactures, sells, and manages cannabis THC and hemp CBD products, including THC concentrates, edibles, distillate cartridges, and related branded merchandise. Its core product portfolio features the Vapen brand, which is a leading line of THC concentrates, edibles, and distillate cartridges produced using the company's in-house grown, high-quality flower. Vext also markets products under the Pure Touch, Appalachian Pharm, Herbal Wellness, and Revibe brands. The company owns and operates state-of-the-art cultivation facilities, fully equipped manufacturing units, and retail dispensaries primarily located in Arizona and Ohio. It provides additional services such as management, advisory, cultivation, non-cannabis product offerings, and dispensary operations through direct sales and joint operational agreements. Founded in 2015 and headquartered in Phoenix, Arizona, Vext Science focuses on vertically integrated cannabis operations across key U.S. markets, leveraging its cultivation, manufacturing, branding, and retail capabilities. Recent major company developments include the expansion of its retail footprint in Ohio to five consolidated dispensary locations with regulatory approval to reach the state's dispensary license cap of eight by 2026. This expansion underpins significant revenue growth, with the company reporting a 41% year-over-year revenue increase to $12.7 million driven by Ohio operations and steady performance in Arizona. The company completed the acquisition of the Herbal Wellness Center dispensary in Portsmouth, Ohio, in October 2025, further strengthening its market presence. Vext continues to focus on operational discipline and growth through new dispensary construction, licensing advances, and product innovation, positioning itself for sustainable, profitable expansion in its core states. Vext Science serves a broad customer base through its diversified cannabis product offerings and retail dispensary network, operating in the specialty drug manufacturing and healthcare sectors. Its leadership maintains a proven track record in building and operating profitable multi-state cannabis operations, emphasizing high-quality product development and effective market penetration in the adult-use cannabis market. The company was formerly known as Vapen MJ Ventures Corporation until its name change to Vext Science, Inc. in November 2019. It operates within the U.S. cannabis market with an ongoing strategic focus on growth, innovation, and market share expansion in both cultivation and retail segments. Recent operational excellence and financial performance improvements highlight its trajectory toward sustained market leadership in Arizona and Ohio.
Vext Opens Sixth Ohio Dispensary in Fairfield
Vext Science Inc. (VEXTF) Q1 2026 Earnings Call Transcript
Vext Reports Q1 2026 Financial Results; Adjusted EBITDA up 73% Sequentially to $3.6 Million as Ohio Platform Scales
Vext Engages Zuanic & Associates
Vext Announces Date for Q1 2026 Financial Results Release
Vext Science Inc. (VEXTF) Q4 2025 Earnings Call Transcript
Vext Reports Q4 and FY 2025; Fiscal 2025 Revenue up +43% to $51.4M, Operating Cash Flow up +256% to $11.7M as Ohio Retail Scales
Vext Announces Revised Date for Q4 and Fiscal 2025 Financial Results Release
Vext Science Announces Strategic Optimization of Arizona Operations and Plans for Ohio Cultivation Expansion
Vext Advances Ohio Expansion with Seventh Retail Location
Vext Science (OTCMKTS:VEXTF) Stock Price Up 14.2% – What’s Next?
Vext Announces Voting Results of Annual General Meeting
CORRECTION FROM SOURCE: Vext Reports Q3 2025 Financial Results
Vext Science Inc. (VEXTF) Q3 2025 Earnings Call Transcript
Vext Reports Q3 2025 Financial Results; Revenue Up 41% Year-over-Year and Operating Cash Flow Year-To-Date Reaches $8.5 Million
Vext to Announce Financial Results for Q3 2025 on November 20, 2025
Vext Secures State Approval for Portsmouth Dispensary Ownership Transfer
Vext Science Inc. (VEXTF) Q2 2025 Earnings Call Transcript
Vext Announces Q2 2025 Financial Results: Record Quarterly Revenue with Strong 31% Cash Flow Margin
Vext to Announce Financial Results for Q2 2025 on August 20, 2025